Cargando…

Can tocilizumab calm the cytokine storm of COVID-19?

Detalles Bibliográficos
Autor principal:	Schulert, Grant S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314441/ https://www.ncbi.nlm.nih.gov/pubmed/32835248 http://dx.doi.org/10.1016/S2665-9913(20)30210-1

Ejemplares similares

CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020)

Accelerating measles elimination in the Western Pacific Region during the calm between the storms
por: Durrheim, David N., et al.
Publicado: (2022)

COVID-19 cytokine storm: targeting the appropriate cytokine
por: Cron, Randy Q
Publicado: (2021)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021)

No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022)

Calming the Cytokine Storm in Pneumonia by Biomimetic Nanoparticles
por: Xia, Yuqiong, et al.
Publicado: (2020)

COVID-19 cytokine storm syndrome: a threshold concept
por: Chen, Luke Y C, et al.
Publicado: (2021)

COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
por: Ombrello, Michael J., et al.
Publicado: (2021)

Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19
por: Timpani, Cara A., et al.
Publicado: (2020)

Calming The Storm By Sympatholysis
por: Francis, Johnson, et al.
Publicado: (2011)

T cells calm the storm
por: Tufet, Marta
Publicado: (2007)

Calm before the Storm
por: Braga Neto, Manuel B., et al.
Publicado: (2022)

Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm
por: Gonzalez-Rubio, Jesus, et al.
Publicado: (2020)

Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm
por: Peng, Xiang, et al.
Publicado: (2021)

Defining the scourge of COVID-19 hyperinflammatory syndrome
por: Cron, Randy Q, et al.
Publicado: (2020)

GM-CSF in the treatment of COVID-19: a new conductor in the pathogenesis of cytokine storm?
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling
por: Gajjela, Bharath Kumar, et al.
Publicado: (2022)

Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome
por: Sarhan, Neven Mohamed, et al.
Publicado: (2023)

QAnon: The Calm Before the Storm
por: Hodwitz, Omi, et al.
Publicado: (2022)

Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch
por: Lan, Yuejia, et al.
Publicado: (2022)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Bradycardia in Patients With COVID-19: A Calm Before the Storm?
por: Amaratunga, Eluwana A, et al.
Publicado: (2020)

Clinical microbiology laboratories and COVID-19: the calm before the storm
por: M Blondeau, Joseph
Publicado: (2020)

Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm
por: Wang, Zhen, et al.
Publicado: (2022)

Inhaled ACE2-engineered microfluidic microsphere for intratracheal neutralization of COVID-19 and calming of the cytokine storm
por: Wang, Zhen, et al.
Publicado: (2023)

Tocilizumab in COVID-19: some clarity amid controversy
por: Gupta, Shruti, et al.
Publicado: (2021)

Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
por: Monteagudo, Luke Adam, et al.
Publicado: (2020)

Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19
por: Saha, Abinit, et al.
Publicado: (2020)

Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
por: Antinori, Spinello, et al.
Publicado: (2020)

Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

2648. Taming the Cytokine Storm: Baricitinib versus Tocilizumab for COVID-19 Hyperinflammation
por: Radziszewski, Skyler, et al.
Publicado: (2023)

Bladder cancer during the COVID-19 pandemic: the calm before the storm?
por: Sarkis, Julien, et al.
Publicado: (2020)

The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
por: Bellinvia, Salvatore, et al.
Publicado: (2020)

Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022)

Protein Aggregation in the ER: Calm behind the Storm
por: Li, Haisen, et al.
Publicado: (2021)

A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System
por: Zhang, Yimin, et al.
Publicado: (2021)

Pink salmon distribution in Sweden: The calm before the storm?
por: Staveley, Thomas A. B., et al.
Publicado: (2022)

The Calm Before the Storm: A Pheochromocytoma Case Report
por: Trinh, Sally, et al.
Publicado: (2023)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_esg8kkfrncainesgr4dsvvfv48